Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation, but this ...

Despite consistent recommendations from clinical guidelines, data from randomized trials on a long-term antithrombotic treatment strategy for patients with atrial fibrillation and stable coronary ...

With the currently available antithrombotic agents, patients with cancer still have unmet needs in terms of the prevention and treatment of thrombosis. Although long-term LMWH is the treatment of ...

France: A recent case report published in the International Journal of Surgery Case Reports has brought attention to a rare ...

Finding the right antithrombotic (anti-clotting) drug for you. ScienceDaily . Retrieved April 29, 2025 from www.sciencedaily.com / releases / 2016 / 01 / 160128094606.htm ...

Antithrombotic therapy in clinically stable, nonhospitalized COVID-19 patients does not offer protection against adverse cardiovascular or pulmonary events, new randomized clinical trial results ...

More than 80% of hospitals surveyed lacked a specific protocol for reversal of antithrombotic agents in critically ill ...

Indeed, this approach has had success in cardiology in terms of blood vessel opening, said Adeoye, adding that some preclinical data suggest that antithrombotic drugs may be neuroprotective.

From the antithrombotic perspective, the two important changes are one on dual antithrombotic therapy following the in-hospital phase for patients with a requirement of oral anticoagulation ...

Antithrombotic drugs are an integral part of the pharmacological treatment regimens, and interventional strategies are currently recommended for thrombotic complications in patients with thrombosis.